Request Free Sample ×
ReportInfographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Vascular Closure Devices Market Share

ID: MRFR/HC/4249-HCR
200 Pages
Vikita Thakur
Last Updated: April 06, 2026

Vascular Closure Devices Market Research Report: Size, Share, Trend Analysis By Device Type (Passive Closure Devices, Active Closure Devices, Suture Closure Devices, Collagen-based Closure Devices), By Procedure Type (Transvascular Procedures, Cardiac Procedures, Peripheral Procedures), By End Users (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Distribution Channel (Direct Sales, Online Sales, Third-party Distributors) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Vascular Closure Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Methodology Download PDF

Market Share

Vascular Closure Devices Market Share Analysis

The market for Vascular Closure Devices (VCD) is fast-moving and tough inside the healthcare world. It's growing because there are more heart treatments happening all over. Strategies for getting a good share of the market are very important to businesses in this area. They help their growth and how long they can last. A main method used by businesses in the DVD market is making their products different from others. Creating new and improved closure devices that keep patients safe, work well and are comfortable lets companies find a special place in the market. Special things, like being easy to use and taking less time, help make businesses stand out more. This leads to them having a bigger share of the market. It's important to keep up with tech changes in the world of VCD sales. Companies spend money on research and development to bring in new technologies, like using bioabsorbable material and expert blood-stopping methods. This brings in health workers looking for new answers and helps them be the top brand. Working with healthcare places, important people and others in the business is very helpful for getting a good position in sales. By making smart partnerships, VCD makers can get more customers and ways to sell their products. They also learn from market trends that help them grow better. These team-ups also help with shared studies, making the company's trust and standing stronger in business. As the healthcare business is worldwide, firms in video cassette distribution often try to grow bigger by reaching more places. Getting into new markets and being strong in areas with lots of heart problems helps businesses get more customers. This makes them share the market better. It's important to make marketing plans for healthcare workers that fit their special needs and choices. Workshops and classes that show the benefits of certain closure devices can help doctors trust them more. This focused method makes sure the product is liked by customers, helping it grow longer in market share. The VCD market requires strong rules and top-quality products to be made. This is not optional. Businesses that make sure they follow the rules and always provide safe products win people's trust. This makes their place in the market stronger. It also helps create trust between medical professionals and patients too. In a market where people care about cost, using fair price ways is very important. Companies can get many health care places by balancing how much they make something with what people think it's worth.

Author
Author Profile
Vikita Thakur
Senior Research Analyst

She holds an experience of about 5+ years in market research and business consulting projects for sectors such as life sciences, medical devices, and healthcare IT. She possesses a robust background in data analysis, market estimation, competitive intelligence, pipeline analysis market trend identification, and consumer behavior insights. Her expertise lies in technical Sales support, client interaction and project management, designing and implementing market research studies, conducting competitive analysis, and synthesizing complex data into actionable recommendations that drive business growth.

Get In Touch

Leave a Comment

FAQs

What is the current market valuation of the Vascular Closure Devices Market?

<p>As of 2024, the market valuation of the Vascular Closure Devices Market was 1.5 USD Billion.</p>

What is the projected market size for the Vascular Closure Devices Market by 2035?

<p>The market is projected to reach approximately 3.217 USD Billion by 2035.</p>

What is the expected CAGR for the Vascular Closure Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Vascular Closure Devices Market during the forecast period 2025 - 2035 is 7.18%.</p>

Which companies are considered key players in the Vascular Closure Devices Market?

<p>Key players in the market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Medtronic, Boston Scientific, Johnson & Johnson, B. Braun Melsungen AG, Vascular Solutions, and Merit Medical Systems.</p>

What are the main types of vascular closure devices and their market valuations?

<p>The main types include Passive Closure Devices valued at 0.95 USD Billion, Active Closure Devices at 1.15 USD Billion, Suture Closure Devices at 0.65 USD Billion, and Collagen-based Closure Devices at 0.47 USD Billion.</p>

What is the market performance of vascular closure devices used in transvascular procedures?

<p>Vascular closure devices for transvascular procedures had a market valuation of 1.3 USD Billion in 2024.</p>

How do hospitals compare to other end users in the Vascular Closure Devices Market?

<p>In 2024, hospitals represented a market valuation of 1.5 USD Billion, outperforming ambulatory surgical centers and specialty clinics.</p>

What distribution channels are utilized in the Vascular Closure Devices Market?

<p>The distribution channels include Direct Sales valued at 1.5 USD Billion, Online Sales at 0.9 USD Billion, and Third-party Distributors at 0.6 USD Billion.</p>

What is the market valuation for vascular closure devices used in cardiac procedures?

<p>The market valuation for vascular closure devices used in cardiac procedures was 1.1 USD Billion in 2024.</p>

What is the projected growth trend for vascular closure devices in peripheral procedures?

<p>The market for vascular closure devices in peripheral procedures is expected to grow from 0.8 USD Billion in 2024 to higher valuations by 2035.</p>

Market Summary

As per Market Research Future analysis, the Vascular Closure Devices Market was estimated at 1.5 USD Billion in 2024. The vascular closure devices industry is projected to grow from 1.608 USD Billion in 2025 to 3.217 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 7.18% during the forecast period 2025 - 2035

Key Market Trends & Highlights

The Vascular Closure Devices Market is experiencing robust growth driven by technological advancements and increasing demand for minimally invasive procedures.

  • North America remains the largest market for vascular closure devices, driven by advanced healthcare infrastructure and high patient awareness. The Asia-Pacific region is emerging as the fastest-growing market, fueled by increasing healthcare investments and a rising prevalence of cardiovascular diseases. Passive closure devices dominate the market, while active closure devices are witnessing the fastest growth due to their enhanced efficacy and patient outcomes. Key market drivers include technological advancements in vascular closure devices and the rising healthcare expenditure associated with aging populations.

Market Size & Forecast

2024 Market Size 1.5 (USD Billion)
2035 Market Size 3.217 (USD Billion)
CAGR (2025 - 2035) 7.18%
Largest Regional Market Share in 2024 North America

Major Players

<a href="https://www.cardiovascular.abbott/us/en/hcp/products/peripheral-intervention/vessel-closure.html">Abbott Laboratories</a>  (US), Terumo Corporation (JP), Cardinal Health (US), Medtronic (US), Boston Scientific (US), Johnson &amp; Johnson (US), B. Braun Melsungen AG (DE), Vascular Solutions (US), Merit Medical Systems (US). These companies play a pivotal role in the development of advanced <strong>vascular closure systems</strong> and innovative <strong>vcd devices</strong>, strengthening competition across the global market

Market Trends

The Vascular Closure Devices Market is currently experiencing a notable transformation, driven by advancements in technology and an increasing emphasis on minimally invasive procedures. As healthcare providers seek to enhance patient outcomes and reduce recovery times, the demand for innovative closure solutions is on the rise. This market appears to be characterized by a growing preference for devices that offer improved safety profiles and ease of use, including next-generation arterial closure devices. Furthermore, the integration of digital health technologies into vascular procedures is likely to reshape the vascular closure device market, enabling better monitoring and management of patient care. In addition, the market seems to be influenced by an aging population and a corresponding rise in cardiovascular diseases. As the prevalence of these conditions escalates, healthcare systems are compelled to adopt more efficient and effective endovascular closure techniques. Overall, the future of this market appears promising, with ongoing innovations and a focus on patient-centric solutions driving growth across the vascular closure market.

Technological Advancements

The Vascular Closure Devices Market is witnessing a surge in technological innovations, which are enhancing the efficacy and safety of closure devices. New materials and designs are being developed to improve the performance of vascular closure systems, making them more reliable and user-friendly. This trend suggests that manufacturers are increasingly investing in research and development to create next-generation products that address the evolving types of vascular closure devices used in clinical practice.

Minimally Invasive Procedures

There is a growing trend toward minimally invasive surgical techniques within the Vascular Closure Devices Market. As patients and healthcare professionals recognize the benefits of reduced recovery times and lower complication rates, the demand for vcd devices that facilitate these procedures is increasing. This shift reflects a broader movement toward patient-centered care and advanced endovascular closure solutions in vascular interventions.

Aging Population and Rising Cardiovascular Diseases

The demographic shift toward an older population is significantly impacting the Vascular Closure Devices Market. As age-related cardiovascular conditions become more prevalent, the need for effective arterial closure devices and reliable vascular closure systems is expected to rise. This trend highlights the importance of addressing healthcare challenges associated with an aging society while reinforcing long-term growth prospects for the vascular closure device market.

Vascular Closure Devices Market Market Drivers

Minimally Invasive Procedures

The trend towards minimally invasive procedures is significantly influencing the Vascular Closure Devices Market. As healthcare providers increasingly adopt less invasive techniques, the demand for vascular closure devices that facilitate these procedures is likely to rise. Minimally invasive surgeries are associated with shorter recovery times, reduced hospital stays, and lower risk of complications, making them appealing to both patients and healthcare professionals. This shift is reflected in the growing number of procedures performed annually, with estimates suggesting that minimally invasive techniques account for over 60% of vascular surgeries. Consequently, the market for vascular closure devices is expected to expand as these devices become integral to the success of such procedures.

Rising Healthcare Expenditure

The increase in healthcare expenditure is a notable driver for the Vascular Closure Devices Market. As countries invest more in healthcare infrastructure and services, the availability of advanced medical technologies, including vascular closure devices, is likely to improve. This trend is particularly evident in regions where healthcare budgets are expanding to accommodate rising patient demands and technological advancements. According to recent data, healthcare spending is projected to grow at an annual rate of 5% over the next several years, which could translate into increased procurement of vascular closure devices. This financial commitment to healthcare is expected to bolster the market, facilitating the adoption of innovative solutions.

Regulatory Approvals and Market Access

Regulatory approvals play a pivotal role in shaping the Vascular Closure Devices Market. The process of obtaining necessary certifications and clearances can significantly impact the speed at which new devices enter the market. Recent trends indicate that regulatory bodies are streamlining approval processes for innovative vascular closure devices, which may enhance market access for manufacturers. This is particularly relevant as companies strive to introduce advanced solutions that meet evolving clinical needs. The ability to navigate regulatory landscapes effectively can provide a competitive edge, potentially leading to increased market share and revenue growth for those who succeed.

Aging Population and Rising Cardiovascular Diseases

The demographic shift towards an aging population is a critical driver for the Vascular Closure Devices Market. As individuals age, the prevalence of cardiovascular diseases tends to increase, leading to a higher demand for vascular interventions. Reports indicate that cardiovascular diseases are among the leading causes of morbidity and mortality worldwide, necessitating effective treatment options. The World Health Organization has projected that by 2030, cardiovascular diseases will account for approximately 23 million deaths annually. This alarming trend underscores the need for efficient vascular closure devices that can support various cardiovascular procedures, thereby propelling market growth.

Technological Advancements in Vascular Closure Devices

The Vascular Closure Devices Market is experiencing a surge in innovation, driven by advancements in technology. New materials and designs are being developed to enhance the efficacy and safety of vascular closure devices. For instance, the introduction of bioresorbable materials is gaining traction, as they offer the potential for reduced complications and improved patient outcomes. Furthermore, the integration of digital technologies, such as real-time imaging and monitoring systems, is likely to enhance procedural accuracy. According to recent estimates, the market for vascular closure devices is projected to grow at a compound annual growth rate of approximately 7% over the next few years, indicating a robust demand for technologically advanced solutions.

Market Segment Insights

By Type: Passive Closure Devices (Largest) vs. Active Closure Devices (Fastest-Growing)

The Vascular Closure Devices Market has shown significant distribution across various types, with Passive Closure Devices holding the largest share. This segment dominates due to its simplicity and effectiveness in achieving hemostasis without additional mechanisms. On the other hand, Active Closure Devices are emerging rapidly, supported by innovations in <strong>vascular closure systems</strong> that improve procedural efficiency. These developments are reshaping the <strong>types of vascular closure devices</strong> preferred by healthcare providers.<br>Growth trends in this segment reveal a shift towards Active Closure Devices, which are becoming the fastest-growing category. The increasing demand for minimally invasive procedures and the rising awareness of the benefits of faster recovery times drive this growth. Manufacturers are investing in research and development to enhance the efficacy of Active Closure Devices, leading to improved adoption rates across hospitals and surgical centers.

Passive Closure Devices (Dominant) vs. Active Closure Devices (Emerging)

Passive Closure Devices are recognized for their straightforward approach and reliability, often utilizing a passive mechanism to achieve hemostasis. Their dominance in the market is fueled by their broad acceptance among healthcare providers, largely due to the minimized risk of complications during procedures. In contrast, Active Closure Devices represent an emerging technology trend within the market. These devices actively engage in the closure process, often using mechanical or adhesive means, to promote quicker closure times and potentially better recovery outcomes for patients. As healthcare providers increasingly seek innovations that enhance surgical efficiency, Active Closure Devices are gaining traction, supported by ongoing clinical research and favorable feedback on their performance.

By Procedure Type: Transvascular Procedures (Largest) vs. Cardiac Procedures (Fastest-Growing)

In the Vascular Closure Devices Market, the distribution of market share is prominently led by Transvascular Procedures that constitute the largest segment, driven by the growing number of minimally invasive interventions requiring reliable <strong>endovascular closure</strong> solutions. Cardiac Procedures are the fastest-growing segment, supported by increasing cardiovascular disease prevalence and advancements in <strong>arterial closure devices</strong>. Cardiac Procedures also maintain a significant position within the market, but they are currently in a phase of rapid growth due to advancing technologies and the rising incidence of cardiac ailments requiring intervention.

Transvascular Procedures (Dominant) vs. Cardiac Procedures (Emerging)

Transvascular Procedures are characterized by their established presence and indispensable role in various minimally invasive surgical operations. This segment benefits from technological advancements that improve procedural efficiency and patient outcomes. In contrast, Cardiac Procedures are emerging swiftly, driven by innovations in device design and an increasing focus on reducing procedure recovery times. Both segments are positioned favorably within the market; however, the urgency of cardiac interventions gives Cardiac Procedures a distinct edge in growth potential as healthcare providers adopt newer technologies to enhance treatment efficacy.

By End User: Hospitals (Largest) vs. Specialty Clinics (Fastest-Growing)

The Vascular Closure Devices Market is predominantly driven by hospitals, which hold the largest market share in the end user segment. With advanced surgical capabilities and a high volume of vascular procedures performed, Hospitals dominate the market due to high procedural volumes and established use of <strong>vascular closure systems</strong>. Specialty clinics are emerging rapidly, driven by focused care models and faster adoption of advanced <strong>vcd devices</strong>. Solutions such as <strong><a href="https://www.marketresearchfuture.com/reports/cardinal-health-market-66150" target="_blank" title="cardinal health">cardinal health</a> access closure</strong> products are gaining traction across both hospitals and specialty clinics.<br><br>Growth trends in the end user segment point towards an increasing adoption of vascular closure devices in ambulatory surgical centers and specialty clinics. The push for minimally invasive surgical solutions is a key driver, as these devices enhance patient recovery times and reduce complications. Furthermore, improved access to healthcare and patient preference for outpatient procedures are accelerating the growth of specialty clinics, making them the fastest-growing segment. This trend indicates a shift in patient management and care strategies, favoring specialized facilities for vascular interventions.

Hospitals (Dominant) vs. Specialty Clinics (Emerging)

Hospitals currently dominate the Vascular Closure Devices Market due to their extensive resources and the ability to perform complex vascular surgeries. These facilities have established protocols for using vascular closure devices, resulting in a consistent demand driven by high surgical volumes. They also benefit from a comprehensive patient care system that integrates these devices into various surgical workflows. On the other hand, specialty clinics are emerging as crucial players in the market. These clinics are often more agile in adopting advanced technologies and are tailored to specific vascular treatments, attracting patients seeking specialized care. This focus on outpatient procedures, combined with enthusiastic adoption of novel closure devices, positions specialty clinics as a key growth area within this segment.

By Distribution Channel: Direct Sales (Largest) vs. Online Sales (Fastest-Growing)

In the Vascular Closure Devices Market, the distribution of sales through various channels shows a clear dominance of direct sales. This channel is preferred by healthcare facilities due to the personalized service and support provided by manufacturers. Direct sales account for a substantial portion of the market share, as they facilitate direct communication between the providers and the manufacturers, strengthening relationships and trust. However, the online sales channel is witnessing rapid growth as more customers are becoming comfortable with purchasing <a href="https://www.marketresearchfuture.com/reports/medical-devices-market-2869" target="_blank" title="medical devices">medical devices</a> online due to the convenience and broader access it provides. Third-party distributors, while significant, play a more supportive role compared to these two channels.

Distribution Channels: Direct Sales (Dominant) vs. Online Sales (Emerging)

Direct sales are characterized by manufacturers directly engaging with hospitals and clinics, offering tailored solutions and close support, which bolsters loyalty and repeat purchases. This channel thrives on strong relationships and ongoing support, allowing for immediate feedback and adjustments. On the other hand, online sales represent an emerging trend in the Vascular Closure Devices Market, driven by the increasing digitalization of healthcare procurement processes. They offer a wider reach and accessibility, particularly advantageous for smaller healthcare facilities that may not have established relationships with manufacturers. Online sales channels are rapidly evolving, benefiting from advancements in technology and growing consumer preference for e-commerce.

Get more detailed insights about Vascular Closure Devices Market Research Report-Forecast to 2035

Regional Insights

North America : Market Leader in Innovation

North America accounts for approximately 45% of the global vascular closure device market, driven by advanced healthcare infrastructure, high cardiovascular disease prevalence, and rapid adoption of endovascular closure technologies. The presence of major players, including Abbott Laboratories, Medtronic, and providers of cardinal health access closure solutions, reinforces regional dominance. The demand for minimally invasive procedures is also on the rise, contributing to market growth.. The competitive environment is characterized by continuous innovation and strategic partnerships among key players. The presence of advanced healthcare facilities and a high prevalence of chronic diseases further bolster the demand for vascular closure devices, making North America a focal point for market activities.

Europe : Emerging Regulatory Frameworks

Europe holds around 30% of the global market share. Growth is driven by regulatory initiatives such as MDR, increased adoption of minimally invasive procedures, and demand for advanced vascular closure systems across Germany, France, and other key markets. Regulatory frameworks, such as the Medical Device Regulation (MDR), are enhancing product safety and efficacy, thereby boosting consumer confidence and market demand. Countries like Germany and France are leading this growth trajectory. Germany stands out as a key player in the European market, with a strong presence of companies like B. Braun Melsungen AG and Terumo Corporation. The competitive landscape is marked by innovation and collaboration among manufacturers to meet evolving healthcare needs. The focus on minimally invasive procedures and improved patient outcomes is driving the adoption of vascular closure devices across Europe, making it a dynamic market for stakeholders.

Asia-Pacific : Rapidly Growing Market Potential

Asia-Pacific represents approximately 20% of the global vascular closure market, supported by rising healthcare investments and increasing cardiovascular procedures. Japan and China are leading adopters of modern vcd devices and cost-effective endovascular closure solutions. The region holds approximately 20% of the global market share, with countries like Japan and China leading the charge. Government initiatives to improve healthcare infrastructure and access to advanced medical technologies are further propelling market growth, making it a key area for investment. Japan is a significant player in this market, with major companies like Terumo Corporation and Cardinal Health actively participating. The competitive landscape is evolving, with local manufacturers emerging alongside established global players. The demand for innovative and cost-effective solutions is high, and the region's focus on improving healthcare outcomes is driving the adoption of vascular closure devices, positioning Asia-Pacific as a vital market for future growth.

Middle East and Africa : Untapped Market Opportunities

The Middle East and Africa region is gradually emerging in the vascular closure devices market, holding about 5% of the global market share. Growth is primarily driven by increasing healthcare investments, rising awareness of cardiovascular diseases, and improving healthcare infrastructure. Countries like South Africa and the UAE are at the forefront of this growth, with government initiatives aimed at enhancing healthcare access and quality. The region's potential is significant, as it continues to attract foreign investments in healthcare technologies. South Africa is a key player in this market, with a growing number of healthcare facilities adopting advanced medical technologies. The competitive landscape is characterized by a mix of local and international players, with a focus on providing affordable and effective healthcare solutions. As the region continues to develop, the demand for vascular closure devices is expected to rise, making it an attractive market for stakeholders looking to expand their footprint.

Key Players and Competitive Insights

The Vascular Closure Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing demand for minimally invasive procedures. Key players such as Abbott Laboratories (US), Medtronic (US), and Boston Scientific (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. Abbott Laboratories (US) emphasizes its commitment to research and development, aiming to introduce cutting-edge solutions that cater to evolving clinical needs. Meanwhile, Medtronic (US) leverages its extensive portfolio to integrate digital health solutions, thereby enhancing patient outcomes and operational efficiency. Boston Scientific (US) appears to be concentrating on expanding its global footprint through strategic acquisitions and collaborations, which collectively shape a competitive environment that is increasingly focused on technological differentiation and patient-centric solutions. In terms of business tactics, companies are increasingly localizing manufacturing to reduce costs and improve supply chain resilience. The market structure is moderately fragmented, with several players vying for market share, yet the influence of major companies remains substantial. This competitive structure fosters an environment where innovation and operational efficiency are paramount, as companies strive to differentiate themselves in a crowded marketplace. In August 2025, Abbott Laboratories (US) announced the launch of a new vascular closure device designed to enhance patient recovery times and reduce complications associated with traditional methods. This strategic move underscores Abbott's focus on innovation and its commitment to addressing the needs of healthcare providers and patients alike. The introduction of this device is likely to strengthen Abbott's market position and could potentially lead to increased adoption in clinical settings. In September 2025, Medtronic (US) unveiled a partnership with a leading telehealth provider to integrate remote monitoring capabilities into its vascular closure devices. This initiative reflects Medtronic's strategy to enhance patient engagement and streamline post-procedure care. By incorporating digital health solutions, Medtronic not only improves patient outcomes but also positions itself as a leader in the evolving landscape of connected healthcare. In July 2025, Boston Scientific (US) completed the acquisition of a smaller firm specializing in innovative vascular technologies. This acquisition is indicative of Boston Scientific's strategy to bolster its product offerings and expand its technological capabilities. By integrating these new technologies, Boston Scientific aims to enhance its competitive edge and address the growing demand for advanced vascular solutions. As of October 2025, the Vascular Closure Devices Market is witnessing trends such as digitalization, sustainability, and the integration of artificial intelligence. These trends are reshaping the competitive landscape, with strategic alliances becoming increasingly important for driving innovation and market penetration. The shift from price-based competition to a focus on technological advancement and supply chain reliability is evident, suggesting that companies will need to prioritize innovation and operational excellence to maintain a competitive advantage in the future.

Key Companies in the Vascular Closure Devices Market include

Industry Developments

Recent developments in the Global Vascular Closure Devices Market have focused on innovation and strategic partnerships. Product launches emphasizing improved safety, faster hemostasis, and next-generation endovascular closure techniques continue to shape the competitive environment. Investments in R&D and sustainability initiatives are further enhancing the long-term outlook of the vascular closure device market. For example, in May 2023, Abbott Laboratories launched an advanced vascular closure device that enhances procedural efficiency and patient safety. Meanwhile, in July 2023, Boston Scientific Corporation announced an extended partnership with a global healthcare provider to improve access to cutting-edge vascular interventions. In terms of mergers and acquisitions, Merit Medical Systems Inc acquired a smaller competitor in March 2023, aiming to expand its product portfolio significantly, improving competitive positioning in the marketplace.

On another front, Terumo Corporation reported a remarkable increase in the adoption of its vascular closure devices, leading to a 15% growth in market valuation in the first quarter of 2023. Notably, the demand for minimally invasive procedures continues to drive market expansion, with increased investments in Research and Development from major companies like Medtronic PLC and Johnson and Johnson targeting innovative vascular solution technologies. Recent trends also indicate a focus on sustainability and environmental impact, with companies striving for eco-friendly device manufacturing processes as part of their corporate social responsibility efforts.

Future Outlook

Vascular Closure Devices Market Future Outlook

The Vascular Closure Devices Market is projected to grow at a 7.18% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular procedures, and rising demand for minimally invasive surgeries.

New opportunities lie in:

  • <p>Development of biodegradable vascular closure devices for enhanced patient safety. Expansion into emerging markets with tailored product offerings. Integration of AI-driven analytics for improved procedural outcomes.</p>

By 2035, the market is expected to achieve substantial growth, solidifying its position as a key segment in the medical device industry.

Market Segmentation

Vascular Closure Devices Market Type Outlook

  • Passive Closure Devices
  • Active Closure Devices
  • Suture Closure Devices
  • Collagen-based Closure Devices

Vascular Closure Devices Market End User Outlook

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Vascular Closure Devices Market Procedure Type Outlook

  • Transvascular Procedures
  • Cardiac Procedures
  • Peripheral Procedures

Vascular Closure Devices Market Distribution Channel Outlook

  • Direct Sales
  • Online Sales
  • Third-party Distributors

Report Scope

MARKET SIZE 2024 1.5(USD Billion)
MARKET SIZE 2025 1.608(USD Billion)
MARKET SIZE 2035 3.217(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.18% (2025 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Abbott Laboratories (US), Terumo Corporation (JP), Cardinal Health (US), Medtronic (US), Boston Scientific (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Vascular Solutions (US), Merit Medical Systems (US)
Segments Covered Device Type, Procedure Type, End Users, Distribution Channel, Regional
Key Market Opportunities Advancements in minimally invasive techniques drive growth in the Vascular Closure Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the vascular closure devices market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current market valuation of the Vascular Closure Devices Market?

<p>As of 2024, the market valuation of the Vascular Closure Devices Market was 1.5 USD Billion.</p>

What is the projected market size for the Vascular Closure Devices Market by 2035?

<p>The market is projected to reach approximately 3.217 USD Billion by 2035.</p>

What is the expected CAGR for the Vascular Closure Devices Market during the forecast period 2025 - 2035?

<p>The expected CAGR for the Vascular Closure Devices Market during the forecast period 2025 - 2035 is 7.18%.</p>

Which companies are considered key players in the Vascular Closure Devices Market?

<p>Key players in the market include Abbott Laboratories, Terumo Corporation, Cardinal Health, Medtronic, Boston Scientific, Johnson & Johnson, B. Braun Melsungen AG, Vascular Solutions, and Merit Medical Systems.</p>

What are the main types of vascular closure devices and their market valuations?

<p>The main types include Passive Closure Devices valued at 0.95 USD Billion, Active Closure Devices at 1.15 USD Billion, Suture Closure Devices at 0.65 USD Billion, and Collagen-based Closure Devices at 0.47 USD Billion.</p>

What is the market performance of vascular closure devices used in transvascular procedures?

<p>Vascular closure devices for transvascular procedures had a market valuation of 1.3 USD Billion in 2024.</p>

How do hospitals compare to other end users in the Vascular Closure Devices Market?

<p>In 2024, hospitals represented a market valuation of 1.5 USD Billion, outperforming ambulatory surgical centers and specialty clinics.</p>

What distribution channels are utilized in the Vascular Closure Devices Market?

<p>The distribution channels include Direct Sales valued at 1.5 USD Billion, Online Sales at 0.9 USD Billion, and Third-party Distributors at 0.6 USD Billion.</p>

What is the market valuation for vascular closure devices used in cardiac procedures?

<p>The market valuation for vascular closure devices used in cardiac procedures was 1.1 USD Billion in 2024.</p>

What is the projected growth trend for vascular closure devices in peripheral procedures?

<p>The market for vascular closure devices in peripheral procedures is expected to grow from 0.8 USD Billion in 2024 to higher valuations by 2035.</p>

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. | 1.1 EXECUTIVE SUMMARY
    2. | | 1.1.1 Market Overview
    3. | | 1.1.2 Key Findings
    4. | | 1.1.3 Market Segmentation
    5. | | 1.1.4 Competitive Landscape
    6. | | 1.1.5 Challenges and Opportunities
    7. | | 1.1.6 Future Outlook
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. | 2.1 MARKET INTRODUCTION
    2. | | 2.1.1 Definition
    3. | | 2.1.2 Scope of the study
    4. | | | 2.1.2.1 Research Objective
    5. | | | 2.1.2.2 Assumption
    6. | | | 2.1.2.3 Limitations
    7. | 2.2 RESEARCH METHODOLOGY
    8. | | 2.2.1 Overview
    9. | | 2.2.2 Data Mining
    10. | | 2.2.3 Secondary Research
    11. | | 2.2.4 Primary Research
    12. | | | 2.2.4.1 Primary Interviews and Information Gathering Process
    13. | | | 2.2.4.2 Breakdown of Primary Respondents
    14. | | 2.2.5 Forecasting Model
    15. | | 2.2.6 Market Size Estimation
    16. | | | 2.2.6.1 Bottom-Up Approach
    17. | | | 2.2.6.2 Top-Down Approach
    18. | | 2.2.7 Data Triangulation
    19. | | 2.2.8 Validation
  3. SECTION III: QUALITATIVE ANALYSIS
    1. | 3.1 MARKET DYNAMICS
    2. | | 3.1.1 Overview
    3. | | 3.1.2 Drivers
    4. | | 3.1.3 Restraints
    5. | | 3.1.4 Opportunities
    6. | 3.2 MARKET FACTOR ANALYSIS
    7. | | 3.2.1 Value chain Analysis
    8. | | 3.2.2 Porter's Five Forces Analysis
    9. | | | 3.2.2.1 Bargaining Power of Suppliers
    10. | | | 3.2.2.2 Bargaining Power of Buyers
    11. | | | 3.2.2.3 Threat of New Entrants
    12. | | | 3.2.2.4 Threat of Substitutes
    13. | | | 3.2.2.5 Intensity of Rivalry
    14. | | 3.2.3 COVID-19 Impact Analysis
    15. | | | 3.2.3.1 Market Impact Analysis
    16. | | | 3.2.3.2 Regional Impact
    17. | | | 3.2.3.3 Opportunity and Threat Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. | 4.1 Healthcare, BY Type (USD Billion)
    2. | | 4.1.1 Passive Closure Devices
    3. | | 4.1.2 Active Closure Devices
    4. | | 4.1.3 Suture Closure Devices
    5. | | 4.1.4 Collagen-based Closure Devices
    6. | 4.2 Healthcare, BY Procedure Type (USD Billion)
    7. | | 4.2.1 Transvascular Procedures
    8. | | 4.2.2 Cardiac Procedures
    9. | | 4.2.3 Peripheral Procedures
    10. | 4.3 Healthcare, BY End User (USD Billion)
    11. | | 4.3.1 Hospitals
    12. | | 4.3.2 Ambulatory Surgical Centers
    13. | | 4.3.3 Specialty Clinics
    14. | 4.4 Healthcare, BY Distribution Channel (USD Billion)
    15. | | 4.4.1 Direct Sales
    16. | | 4.4.2 Online Sales
    17. | | 4.4.3 Third-party Distributors
    18. | 4.5 Healthcare, BY Region (USD Billion)
    19. | | 4.5.1 North America
    20. | | | 4.5.1.1 US
    21. | | | 4.5.1.2 Canada
    22. | | 4.5.2 Europe
    23. | | | 4.5.2.1 Germany
    24. | | | 4.5.2.2 UK
    25. | | | 4.5.2.3 France
    26. | | | 4.5.2.4 Russia
    27. | | | 4.5.2.5 Italy
    28. | | | 4.5.2.6 Spain
    29. | | | 4.5.2.7 Rest of Europe
    30. | | 4.5.3 APAC
    31. | | | 4.5.3.1 China
    32. | | | 4.5.3.2 India
    33. | | | 4.5.3.3 Japan
    34. | | | 4.5.3.4 South Korea
    35. | | | 4.5.3.5 Malaysia
    36. | | | 4.5.3.6 Thailand
    37. | | | 4.5.3.7 Indonesia
    38. | | | 4.5.3.8 Rest of APAC
    39. | | 4.5.4 South America
    40. | | | 4.5.4.1 Brazil
    41. | | | 4.5.4.2 Mexico
    42. | | | 4.5.4.3 Argentina
    43. | | | 4.5.4.4 Rest of South America
    44. | | 4.5.5 MEA
    45. | | | 4.5.5.1 GCC Countries
    46. | | | 4.5.5.2 South Africa
    47. | | | 4.5.5.3 Rest of MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. | 5.1 Competitive Landscape
    2. | | 5.1.1 Overview
    3. | | 5.1.2 Competitive Analysis
    4. | | 5.1.3 Market share Analysis
    5. | | 5.1.4 Major Growth Strategy in the Healthcare
    6. | | 5.1.5 Competitive Benchmarking
    7. | | 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
    8. | | 5.1.7 Key developments and growth strategies
    9. | | | 5.1.7.1 New Product Launch/Service Deployment
    10. | | | 5.1.7.2 Merger & Acquisitions
    11. | | | 5.1.7.3 Joint Ventures
    12. | | 5.1.8 Major Players Financial Matrix
    13. | | | 5.1.8.1 Sales and Operating Income
    14. | | | 5.1.8.2 Major Players R&D Expenditure. 2023
    15. | 5.2 Company Profiles
    16. | | 5.2.1 Abbott Laboratories (US)
    17. | | | 5.2.1.1 Financial Overview
    18. | | | 5.2.1.2 Products Offered
    19. | | | 5.2.1.3 Key Developments
    20. | | | 5.2.1.4 SWOT Analysis
    21. | | | 5.2.1.5 Key Strategies
    22. | | 5.2.2 Terumo Corporation (JP)
    23. | | | 5.2.2.1 Financial Overview
    24. | | | 5.2.2.2 Products Offered
    25. | | | 5.2.2.3 Key Developments
    26. | | | 5.2.2.4 SWOT Analysis
    27. | | | 5.2.2.5 Key Strategies
    28. | | 5.2.3 Cardinal Health (US)
    29. | | | 5.2.3.1 Financial Overview
    30. | | | 5.2.3.2 Products Offered
    31. | | | 5.2.3.3 Key Developments
    32. | | | 5.2.3.4 SWOT Analysis
    33. | | | 5.2.3.5 Key Strategies
    34. | | 5.2.4 Medtronic (US)
    35. | | | 5.2.4.1 Financial Overview
    36. | | | 5.2.4.2 Products Offered
    37. | | | 5.2.4.3 Key Developments
    38. | | | 5.2.4.4 SWOT Analysis
    39. | | | 5.2.4.5 Key Strategies
    40. | | 5.2.5 Boston Scientific (US)
    41. | | | 5.2.5.1 Financial Overview
    42. | | | 5.2.5.2 Products Offered
    43. | | | 5.2.5.3 Key Developments
    44. | | | 5.2.5.4 SWOT Analysis
    45. | | | 5.2.5.5 Key Strategies
    46. | | 5.2.6 Johnson & Johnson (US)
    47. | | | 5.2.6.1 Financial Overview
    48. | | | 5.2.6.2 Products Offered
    49. | | | 5.2.6.3 Key Developments
    50. | | | 5.2.6.4 SWOT Analysis
    51. | | | 5.2.6.5 Key Strategies
    52. | | 5.2.7 B. Braun Melsungen AG (DE)
    53. | | | 5.2.7.1 Financial Overview
    54. | | | 5.2.7.2 Products Offered
    55. | | | 5.2.7.3 Key Developments
    56. | | | 5.2.7.4 SWOT Analysis
    57. | | | 5.2.7.5 Key Strategies
    58. | | 5.2.8 Vascular Solutions (US)
    59. | | | 5.2.8.1 Financial Overview
    60. | | | 5.2.8.2 Products Offered
    61. | | | 5.2.8.3 Key Developments
    62. | | | 5.2.8.4 SWOT Analysis
    63. | | | 5.2.8.5 Key Strategies
    64. | | 5.2.9 Merit Medical Systems (US)
    65. | | | 5.2.9.1 Financial Overview
    66. | | | 5.2.9.2 Products Offered
    67. | | | 5.2.9.3 Key Developments
    68. | | | 5.2.9.4 SWOT Analysis
    69. | | | 5.2.9.5 Key Strategies
    70. | 5.3 Appendix
    71. | | 5.3.1 References
    72. | | 5.3.2 Related Reports
  6. LIST OF FIGURES
    1. | 6.1 MARKET SYNOPSIS
    2. | 6.2 NORTH AMERICA MARKET ANALYSIS
    3. | 6.3 US MARKET ANALYSIS BY TYPE
    4. | 6.4 US MARKET ANALYSIS BY PROCEDURE TYPE
    5. | 6.5 US MARKET ANALYSIS BY END USER
    6. | 6.6 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    7. | 6.7 CANADA MARKET ANALYSIS BY TYPE
    8. | 6.8 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
    9. | 6.9 CANADA MARKET ANALYSIS BY END USER
    10. | 6.10 CANADA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    11. | 6.11 EUROPE MARKET ANALYSIS
    12. | 6.12 GERMANY MARKET ANALYSIS BY TYPE
    13. | 6.13 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
    14. | 6.14 GERMANY MARKET ANALYSIS BY END USER
    15. | 6.15 GERMANY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    16. | 6.16 UK MARKET ANALYSIS BY TYPE
    17. | 6.17 UK MARKET ANALYSIS BY PROCEDURE TYPE
    18. | 6.18 UK MARKET ANALYSIS BY END USER
    19. | 6.19 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    20. | 6.20 FRANCE MARKET ANALYSIS BY TYPE
    21. | 6.21 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
    22. | 6.22 FRANCE MARKET ANALYSIS BY END USER
    23. | 6.23 FRANCE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    24. | 6.24 RUSSIA MARKET ANALYSIS BY TYPE
    25. | 6.25 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
    26. | 6.26 RUSSIA MARKET ANALYSIS BY END USER
    27. | 6.27 RUSSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    28. | 6.28 ITALY MARKET ANALYSIS BY TYPE
    29. | 6.29 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
    30. | 6.30 ITALY MARKET ANALYSIS BY END USER
    31. | 6.31 ITALY MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    32. | 6.32 SPAIN MARKET ANALYSIS BY TYPE
    33. | 6.33 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
    34. | 6.34 SPAIN MARKET ANALYSIS BY END USER
    35. | 6.35 SPAIN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    36. | 6.36 REST OF EUROPE MARKET ANALYSIS BY TYPE
    37. | 6.37 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
    38. | 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER
    39. | 6.39 REST OF EUROPE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    40. | 6.40 APAC MARKET ANALYSIS
    41. | 6.41 CHINA MARKET ANALYSIS BY TYPE
    42. | 6.42 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
    43. | 6.43 CHINA MARKET ANALYSIS BY END USER
    44. | 6.44 CHINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    45. | 6.45 INDIA MARKET ANALYSIS BY TYPE
    46. | 6.46 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
    47. | 6.47 INDIA MARKET ANALYSIS BY END USER
    48. | 6.48 INDIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    49. | 6.49 JAPAN MARKET ANALYSIS BY TYPE
    50. | 6.50 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
    51. | 6.51 JAPAN MARKET ANALYSIS BY END USER
    52. | 6.52 JAPAN MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    53. | 6.53 SOUTH KOREA MARKET ANALYSIS BY TYPE
    54. | 6.54 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
    55. | 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER
    56. | 6.56 SOUTH KOREA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    57. | 6.57 MALAYSIA MARKET ANALYSIS BY TYPE
    58. | 6.58 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
    59. | 6.59 MALAYSIA MARKET ANALYSIS BY END USER
    60. | 6.60 MALAYSIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    61. | 6.61 THAILAND MARKET ANALYSIS BY TYPE
    62. | 6.62 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
    63. | 6.63 THAILAND MARKET ANALYSIS BY END USER
    64. | 6.64 THAILAND MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    65. | 6.65 INDONESIA MARKET ANALYSIS BY TYPE
    66. | 6.66 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
    67. | 6.67 INDONESIA MARKET ANALYSIS BY END USER
    68. | 6.68 INDONESIA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    69. | 6.69 REST OF APAC MARKET ANALYSIS BY TYPE
    70. | 6.70 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
    71. | 6.71 REST OF APAC MARKET ANALYSIS BY END USER
    72. | 6.72 REST OF APAC MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    73. | 6.73 SOUTH AMERICA MARKET ANALYSIS
    74. | 6.74 BRAZIL MARKET ANALYSIS BY TYPE
    75. | 6.75 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
    76. | 6.76 BRAZIL MARKET ANALYSIS BY END USER
    77. | 6.77 BRAZIL MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    78. | 6.78 MEXICO MARKET ANALYSIS BY TYPE
    79. | 6.79 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
    80. | 6.80 MEXICO MARKET ANALYSIS BY END USER
    81. | 6.81 MEXICO MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    82. | 6.82 ARGENTINA MARKET ANALYSIS BY TYPE
    83. | 6.83 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
    84. | 6.84 ARGENTINA MARKET ANALYSIS BY END USER
    85. | 6.85 ARGENTINA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    86. | 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
    87. | 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
    88. | 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    89. | 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    90. | 6.90 MEA MARKET ANALYSIS
    91. | 6.91 GCC COUNTRIES MARKET ANALYSIS BY TYPE
    92. | 6.92 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
    93. | 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER
    94. | 6.94 GCC COUNTRIES MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    95. | 6.95 SOUTH AFRICA MARKET ANALYSIS BY TYPE
    96. | 6.96 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
    97. | 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER
    98. | 6.98 SOUTH AFRICA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    99. | 6.99 REST OF MEA MARKET ANALYSIS BY TYPE
    100. | 6.100 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
    101. | 6.101 REST OF MEA MARKET ANALYSIS BY END USER
    102. | 6.102 REST OF MEA MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    103. | 6.103 KEY BUYING CRITERIA OF HEALTHCARE
    104. | 6.104 RESEARCH PROCESS OF MRFR
    105. | 6.105 DRO ANALYSIS OF HEALTHCARE
    106. | 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    107. | 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    108. | 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE
    109. | 6.109 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    110. | 6.110 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
    111. | 6.111 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
    112. | 6.112 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
    113. | 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE)
    114. | 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    115. | 6.115 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    116. | 6.116 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
    117. | 6.117 BENCHMARKING OF MAJOR COMPETITORS
  7. LIST OF TABLES
    1. | 7.1 LIST OF ASSUMPTIONS
    2. | | 7.1.1
    3. | 7.2 North America MARKET SIZE ESTIMATES; FORECAST
    4. | | 7.2.1 BY TYPE, 2025-2035 (USD Billion)
    5. | | 7.2.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    6. | | 7.2.3 BY END USER, 2025-2035 (USD Billion)
    7. | | 7.2.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    8. | 7.3 US MARKET SIZE ESTIMATES; FORECAST
    9. | | 7.3.1 BY TYPE, 2025-2035 (USD Billion)
    10. | | 7.3.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    11. | | 7.3.3 BY END USER, 2025-2035 (USD Billion)
    12. | | 7.3.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    13. | 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
    14. | | 7.4.1 BY TYPE, 2025-2035 (USD Billion)
    15. | | 7.4.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    16. | | 7.4.3 BY END USER, 2025-2035 (USD Billion)
    17. | | 7.4.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    18. | 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
    19. | | 7.5.1 BY TYPE, 2025-2035 (USD Billion)
    20. | | 7.5.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    21. | | 7.5.3 BY END USER, 2025-2035 (USD Billion)
    22. | | 7.5.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    23. | 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
    24. | | 7.6.1 BY TYPE, 2025-2035 (USD Billion)
    25. | | 7.6.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    26. | | 7.6.3 BY END USER, 2025-2035 (USD Billion)
    27. | | 7.6.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    28. | 7.7 UK MARKET SIZE ESTIMATES; FORECAST
    29. | | 7.7.1 BY TYPE, 2025-2035 (USD Billion)
    30. | | 7.7.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    31. | | 7.7.3 BY END USER, 2025-2035 (USD Billion)
    32. | | 7.7.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    33. | 7.8 France MARKET SIZE ESTIMATES; FORECAST
    34. | | 7.8.1 BY TYPE, 2025-2035 (USD Billion)
    35. | | 7.8.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    36. | | 7.8.3 BY END USER, 2025-2035 (USD Billion)
    37. | | 7.8.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    38. | 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
    39. | | 7.9.1 BY TYPE, 2025-2035 (USD Billion)
    40. | | 7.9.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    41. | | 7.9.3 BY END USER, 2025-2035 (USD Billion)
    42. | | 7.9.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    43. | 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
    44. | | 7.10.1 BY TYPE, 2025-2035 (USD Billion)
    45. | | 7.10.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    46. | | 7.10.3 BY END USER, 2025-2035 (USD Billion)
    47. | | 7.10.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    48. | 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
    49. | | 7.11.1 BY TYPE, 2025-2035 (USD Billion)
    50. | | 7.11.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    51. | | 7.11.3 BY END USER, 2025-2035 (USD Billion)
    52. | | 7.11.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    53. | 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
    54. | | 7.12.1 BY TYPE, 2025-2035 (USD Billion)
    55. | | 7.12.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    56. | | 7.12.3 BY END USER, 2025-2035 (USD Billion)
    57. | | 7.12.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    58. | 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
    59. | | 7.13.1 BY TYPE, 2025-2035 (USD Billion)
    60. | | 7.13.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    61. | | 7.13.3 BY END USER, 2025-2035 (USD Billion)
    62. | | 7.13.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    63. | 7.14 China MARKET SIZE ESTIMATES; FORECAST
    64. | | 7.14.1 BY TYPE, 2025-2035 (USD Billion)
    65. | | 7.14.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    66. | | 7.14.3 BY END USER, 2025-2035 (USD Billion)
    67. | | 7.14.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    68. | 7.15 India MARKET SIZE ESTIMATES; FORECAST
    69. | | 7.15.1 BY TYPE, 2025-2035 (USD Billion)
    70. | | 7.15.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    71. | | 7.15.3 BY END USER, 2025-2035 (USD Billion)
    72. | | 7.15.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    73. | 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
    74. | | 7.16.1 BY TYPE, 2025-2035 (USD Billion)
    75. | | 7.16.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    76. | | 7.16.3 BY END USER, 2025-2035 (USD Billion)
    77. | | 7.16.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    78. | 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
    79. | | 7.17.1 BY TYPE, 2025-2035 (USD Billion)
    80. | | 7.17.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    81. | | 7.17.3 BY END USER, 2025-2035 (USD Billion)
    82. | | 7.17.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    83. | 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
    84. | | 7.18.1 BY TYPE, 2025-2035 (USD Billion)
    85. | | 7.18.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    86. | | 7.18.3 BY END USER, 2025-2035 (USD Billion)
    87. | | 7.18.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    88. | 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
    89. | | 7.19.1 BY TYPE, 2025-2035 (USD Billion)
    90. | | 7.19.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    91. | | 7.19.3 BY END USER, 2025-2035 (USD Billion)
    92. | | 7.19.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    93. | 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
    94. | | 7.20.1 BY TYPE, 2025-2035 (USD Billion)
    95. | | 7.20.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    96. | | 7.20.3 BY END USER, 2025-2035 (USD Billion)
    97. | | 7.20.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    98. | 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
    99. | | 7.21.1 BY TYPE, 2025-2035 (USD Billion)
    100. | | 7.21.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    101. | | 7.21.3 BY END USER, 2025-2035 (USD Billion)
    102. | | 7.21.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    103. | 7.22 South America MARKET SIZE ESTIMATES; FORECAST
    104. | | 7.22.1 BY TYPE, 2025-2035 (USD Billion)
    105. | | 7.22.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    106. | | 7.22.3 BY END USER, 2025-2035 (USD Billion)
    107. | | 7.22.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    108. | 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
    109. | | 7.23.1 BY TYPE, 2025-2035 (USD Billion)
    110. | | 7.23.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    111. | | 7.23.3 BY END USER, 2025-2035 (USD Billion)
    112. | | 7.23.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    113. | 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
    114. | | 7.24.1 BY TYPE, 2025-2035 (USD Billion)
    115. | | 7.24.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    116. | | 7.24.3 BY END USER, 2025-2035 (USD Billion)
    117. | | 7.24.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    118. | 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
    119. | | 7.25.1 BY TYPE, 2025-2035 (USD Billion)
    120. | | 7.25.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    121. | | 7.25.3 BY END USER, 2025-2035 (USD Billion)
    122. | | 7.25.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    123. | 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
    124. | | 7.26.1 BY TYPE, 2025-2035 (USD Billion)
    125. | | 7.26.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    126. | | 7.26.3 BY END USER, 2025-2035 (USD Billion)
    127. | | 7.26.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    128. | 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
    129. | | 7.27.1 BY TYPE, 2025-2035 (USD Billion)
    130. | | 7.27.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    131. | | 7.27.3 BY END USER, 2025-2035 (USD Billion)
    132. | | 7.27.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    133. | 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
    134. | | 7.28.1 BY TYPE, 2025-2035 (USD Billion)
    135. | | 7.28.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    136. | | 7.28.3 BY END USER, 2025-2035 (USD Billion)
    137. | | 7.28.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    138. | 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
    139. | | 7.29.1 BY TYPE, 2025-2035 (USD Billion)
    140. | | 7.29.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    141. | | 7.29.3 BY END USER, 2025-2035 (USD Billion)
    142. | | 7.29.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    143. | 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
    144. | | 7.30.1 BY TYPE, 2025-2035 (USD Billion)
    145. | | 7.30.2 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
    146. | | 7.30.3 BY END USER, 2025-2035 (USD Billion)
    147. | | 7.30.4 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Billion)
    148. | 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    149. | | 7.31.1
    150. | 7.32 ACQUISITION/PARTNERSHIP
    151. | | 7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • Passive Closure Devices
  • Active Closure Devices
  • Suture Closure Devices
  • Collagen-based Closure Devices

Healthcare By Procedure Type (USD Billion, 2025-2035)

  • Transvascular Procedures
  • Cardiac Procedures
  • Peripheral Procedures

Healthcare By End User (USD Billion, 2025-2035)

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Healthcare By Distribution Channel (USD Billion, 2025-2035)

  • Direct Sales
  • Online Sales
  • Third-party Distributors
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓